Crossmark

ACROSTART: A retrospective study of the time to achieve hormonal control with lanreotide Autogel treatment in Spanish patients with acromegaly

Crossref DOI link: https://doi.org/10.1016/j.endien.2019.05.002

Published Print: 2019-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Álvarez-Escolá, Cristina

Venegas-Moreno, Eva María

García-Arnés, Juan Antonio

Blanco-Carrera, Concepción

Marazuela-Azpiroz, Mónica

Gálvez-Moreno, María Ángeles

Menéndez-Torre, Edelmiro

Aller-Pardo, Javier

Salinas-Vert, Isabel

Resmini, Eugenia

Torres-Vela, Elena María

Gonzalo-Redondo, María Ángeles

Vílchez-Joya, Ricardo

de Miguel-Novoa, María Paz

Halperín-Rabinovich, Irene

Páramo-Fernández, Concepción

de la Cruz-Sugranyes, Guillermo

Houchard, Aude

Picó-Alfonso, Antonio Miguel
Funding

Funding for this research was provided by:

Ipsen Pharma S.A., Spain
License Information

Text and Data Mining valid from 2019-05-01
More Information

This article is maintained by: Elsevier

Article Title: ACROSTART: A retrospective study of the time to achieve hormonal control with lanreotide Autogel treatment in Spanish patients with acromegaly

Journal Title: Endocrinología, Diabetes y Nutrición (English ed.)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.endien.2019.05.002

Content Type: article

Copyright: © 2019 SEEN and SED. Published by Elsevier España, S.L.U. All rights reserved.